EA202191216A1 - НОВЫЕ 6,7-ДИГИДРО-4Н-ПИРАЗОЛО[1,5-a]ПИРАЗИН-ИНДОЛ-2-КАРБОКСАМИДЫ, АКТИВНЫЕ ПРОТИВ ВИРУСА ГЕПАТИТА B (HBV) - Google Patents
НОВЫЕ 6,7-ДИГИДРО-4Н-ПИРАЗОЛО[1,5-a]ПИРАЗИН-ИНДОЛ-2-КАРБОКСАМИДЫ, АКТИВНЫЕ ПРОТИВ ВИРУСА ГЕПАТИТА B (HBV)Info
- Publication number
- EA202191216A1 EA202191216A1 EA202191216A EA202191216A EA202191216A1 EA 202191216 A1 EA202191216 A1 EA 202191216A1 EA 202191216 A EA202191216 A EA 202191216A EA 202191216 A EA202191216 A EA 202191216A EA 202191216 A1 EA202191216 A1 EA 202191216A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- hbv
- virus
- pyrazolo
- indol
- pyrazine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Настоящее изобретение в целом относится к новым противовирусным средствам. В частности, настоящее изобретение относится к соединениям, которые могут ингибировать белок или белки, кодируемые вирусом гепатита B (HBV), или влиять на функцию цикла репликации HBV, к композициям, содержащим такие соединения, способам ингибирования репликации вируса HBV, способам лечения или профилактики инфекции HBV, а также к способам и промежуточным соединениям для получения указанных соединений.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP18000876 | 2018-11-02 | ||
PCT/EP2019/079965 WO2020089453A1 (en) | 2018-11-02 | 2019-11-01 | Novel 6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine indole-2-carboxamides active against the hepatitis b virus (hbv) |
Publications (1)
Publication Number | Publication Date |
---|---|
EA202191216A1 true EA202191216A1 (ru) | 2021-08-03 |
Family
ID=64362286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA202191216A EA202191216A1 (ru) | 2018-11-02 | 2019-11-01 | НОВЫЕ 6,7-ДИГИДРО-4Н-ПИРАЗОЛО[1,5-a]ПИРАЗИН-ИНДОЛ-2-КАРБОКСАМИДЫ, АКТИВНЫЕ ПРОТИВ ВИРУСА ГЕПАТИТА B (HBV) |
Country Status (20)
Country | Link |
---|---|
US (1) | US20220363686A1 (ru) |
EP (1) | EP3873909A1 (ru) |
JP (1) | JP2022512871A (ru) |
KR (1) | KR20210099562A (ru) |
CN (1) | CN113056467A (ru) |
AR (1) | AR116947A1 (ru) |
AU (1) | AU2019370994A1 (ru) |
BR (1) | BR112021008361A2 (ru) |
CA (1) | CA3118380A1 (ru) |
CL (1) | CL2021001117A1 (ru) |
CU (1) | CU20210038A7 (ru) |
EA (1) | EA202191216A1 (ru) |
EC (1) | ECSP21031085A (ru) |
IL (1) | IL282480A (ru) |
MX (1) | MX2021004986A (ru) |
PH (1) | PH12021550979A1 (ru) |
SG (1) | SG11202104130SA (ru) |
TW (1) | TW202031661A (ru) |
UY (1) | UY38436A (ru) |
WO (1) | WO2020089453A1 (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR117188A1 (es) * | 2018-11-02 | 2021-07-21 | Aicuris Gmbh & Co Kg | Derivados de urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas activas contra el virus de la hepatitis b (vhb) |
AR117189A1 (es) * | 2018-11-02 | 2021-07-21 | Aicuris Gmbh & Co Kg | Derivados de 6,7-dihidro-4h-pirazolo[1,5-a]pirazin indol-2-carboxamidas activos contra el virus de la hepatitis b (vhb) |
KR20220156535A (ko) | 2020-02-07 | 2022-11-25 | 가셔브룸 바이오, 인크. | 헤테로사이클릭 glp-1 작용제 |
US20230331732A1 (en) * | 2020-09-10 | 2023-10-19 | Gasherbrum Bio, Inc. | Heterocyclic glp-1 agonists |
Family Cites Families (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19817264A1 (de) | 1998-04-18 | 1999-10-21 | Bayer Ag | Neue Dihydropyrimidine |
WO2000058302A1 (de) | 1999-03-25 | 2000-10-05 | Bayer Aktiengesellschaft | Dihydropyrimidine und ihre verwendung zur behandlung von hepatitis b |
WO2001006840A1 (en) | 1999-04-23 | 2001-02-01 | Jonathan Dallas Toye | Sheet fastening and anchoring component |
WO2001045712A1 (de) | 1999-12-22 | 2001-06-28 | Bayer Aktiengesellschaft | Arzneimittelkombinationen gegen virale erkrankungen |
WO2006033995A2 (en) | 2004-09-16 | 2006-03-30 | Valeant Research And Development | Thiazolidin-4-ones having anti-hepatitis b activity |
US7943617B2 (en) * | 2006-11-27 | 2011-05-17 | Bristol-Myers Squibb Company | Heterobicyclic compounds useful as kinase inhibitors |
JP5977347B2 (ja) | 2011-07-01 | 2016-08-24 | バルーク エス.ブルームバーグ インスティテュート | Hbv感染に対する抗ウイルス剤としてのスルファモイルベンズアミド誘導体 |
EA037918B1 (ru) | 2011-12-21 | 2021-06-07 | Новира Терапьютикс, Инк. | Противовирусные агенты против гепатита в |
AU2013207205B2 (en) | 2012-01-06 | 2017-02-02 | Janssen Sciences Ireland Uc | 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of Hepatitis B |
US9096579B2 (en) * | 2012-04-20 | 2015-08-04 | Boehringer Ingelheim International Gmbh | Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments |
CR20200276A (es) | 2012-08-28 | 2021-01-27 | Janssen Sciences Ireland Uc | Sulfamoilarilamidas y su uso como medicamentos para el tratamientos de la hepatitis b (divisional exp. 2015-0059) |
DK2890683T3 (en) | 2012-08-28 | 2017-01-30 | Janssen Sciences Ireland Uc | MERGED BICYCLIC SULFAMOYL DERIVATIVES AND THEIR USE AS MEDICINES TO TREAT HEPATITIS B |
WO2014165128A2 (en) | 2013-03-12 | 2014-10-09 | Novira Therapeutics, Inc. | Hepatitis b antiviral agents |
JP6533217B2 (ja) | 2013-05-17 | 2019-06-19 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | B型肝炎ウイルス感染症の治療および予防のための6−架橋ヘテロアリールジヒドロピリミジン類 |
CN105960400B (zh) | 2013-05-17 | 2019-05-31 | 爱尔兰詹森科学公司 | 氨磺酰基噻吩酰胺衍生物及其作为药物用于治疗乙型肝炎的用途 |
WO2015011281A1 (en) | 2013-07-25 | 2015-01-29 | Janssen R&D Ireland | Glyoxamide substituted pyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis b |
AU2014337298B2 (en) | 2013-10-18 | 2018-12-06 | Indiana University Research And Technology Corporation | Hepatitis B viral assembly effectors |
AU2014348518B2 (en) | 2013-11-14 | 2019-01-03 | Novira Therapeutics, Inc. | Azepane derivatives and methods of treating hepatitis B infections |
US9169212B2 (en) | 2014-01-16 | 2015-10-27 | Novira Therapeutics, Inc. | Azepane derivatives and methods of treating hepatitis B infections |
RS58384B1 (sr) | 2014-03-07 | 2019-04-30 | Hoffmann La Roche | Novi 6-fuzionisani heteroarildihidropirimidini za lečenje i profilaksu infekcije virusom hepatitisa b |
ES2748029T3 (es) | 2014-03-13 | 2020-03-12 | Univ Indiana Res & Tech Corp | Moduladores alostéricos de proteína núcleo de hepatitis B |
CA2938050A1 (en) | 2014-03-28 | 2015-10-01 | Sunshine Lake Pharma Co., Ltd. | Dihydropyrimidine compounds and their application in pharmaceuticals |
EP3139954A4 (en) | 2014-05-09 | 2018-02-28 | Indiana University Research and Technology Corporation | Methods and compositions for treating hepatitis b virus infections |
CA2952541C (en) | 2014-08-14 | 2019-10-01 | F. Hoffmann-La Roche Ag | Pyridazones and triazinones for the treatment and prophylaxis of hepatitis b virus infection |
CN107406378A (zh) | 2014-12-02 | 2017-11-28 | 诺维拉治疗公司 | 用于hbv治疗的硫化烷基化合物和吡啶类反式磺酰胺化合物 |
CA2972434A1 (en) | 2014-12-30 | 2016-07-07 | Novira Therapeutics, Inc. | Derivatives and methods of treating hepatitis b infections |
MA41338B1 (fr) | 2015-01-16 | 2019-07-31 | Hoffmann La Roche | Composés de pyrazine pour le traitement de maladies infectieuses |
CR20170424A (es) | 2015-03-16 | 2018-01-26 | Hoffmann La Roche | Tratamiento combinado con un agonista de tlr7 y un inhibidor del ensamblaje de la cápsula del vhb |
WO2016161268A1 (en) | 2015-04-01 | 2016-10-06 | Enanta Pharmaceuticals, Inc. | Hepatitis b antviral agents |
EP3292120B1 (en) | 2015-05-04 | 2019-06-19 | H. Hoffnabb-La Roche Ag | Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of hbsag (hbv surface antigen) and hbv dna production for the treatment of hepatitis b virus infections |
US10738035B2 (en) | 2015-05-13 | 2020-08-11 | Enanta Pharmaceuticals, Inc. | Hepatitis B antiviral agents |
US10875876B2 (en) | 2015-07-02 | 2020-12-29 | Janssen Sciences Ireland Uc | Cyclized sulfamoylarylamide derivatives and the use thereof as medicaments for the treatment of hepatitis B |
WO2017011552A1 (en) | 2015-07-13 | 2017-01-19 | Enanta Pharmaceuticals, Inc. | Hepatitis b antiviral agents |
EP3325477B1 (en) | 2015-07-21 | 2019-05-01 | H. Hoffnabb-La Roche Ag | Novel tricyclic 4-pyridone-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis b virus infection |
WO2017015451A1 (en) | 2015-07-22 | 2017-01-26 | Enanta Pharmaceuticals, Inc. | Hepatitis b antiviral agents |
TW201720802A (zh) | 2015-09-15 | 2017-06-16 | 艾森伯利生物科學公司 | B型肝炎核心蛋白質調節劑 |
JP6845231B2 (ja) | 2015-09-29 | 2021-03-17 | ノヴィラ・セラピューティクス・インコーポレイテッド | B型肝炎抗ウイルス薬の結晶形態 |
EP3372606B1 (en) | 2015-11-04 | 2020-04-08 | Qilu Pharmaceutical Co., Ltd | Crystal form, preparation method and intermediate of dihydropyrido ring compound |
WO2017136403A1 (en) | 2016-02-02 | 2017-08-10 | Enanta Pharmaceuticals, Inc. | Hepatitis b antiviral agents |
EP3426245B1 (en) | 2016-03-07 | 2022-12-14 | Enanta Pharmaceuticals, Inc. | Hepatitis b antiviral agents |
JP6957518B2 (ja) * | 2016-05-20 | 2021-11-02 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 感染症の治療のための酸素、硫黄および窒素リンカーを有する新規ピラジン化合物 |
WO2018011162A1 (en) | 2016-07-14 | 2018-01-18 | F. Hoffmann-La Roche Ag | Carboxy 6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine compounds for the treatment of infectious diseases |
WO2018011160A1 (en) | 2016-07-14 | 2018-01-18 | F. Hoffmann-La Roche Ag | 6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine compounds for the treatment of infectious diseases |
WO2018011163A1 (en) | 2016-07-14 | 2018-01-18 | F. Hoffmann-La Roche Ag | 6,7-dihydro-4h-pyrazolo[1,5-a]pyrazine and 6,7-dihydro-4h-triazolo[1,5-a]pyrazine compounds for the treatment of infectious diseases |
JOP20190024A1 (ar) | 2016-08-26 | 2019-02-19 | Gilead Sciences Inc | مركبات بيروليزين بها استبدال واستخداماتها |
US11001564B2 (en) | 2016-09-13 | 2021-05-11 | Arbutus Biopharma Corporation | Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same |
CA3055194A1 (en) | 2017-03-02 | 2018-09-07 | Assembly Biosciences, Inc. | Cyclic sulfamide compounds and methods of using same |
CA3056886A1 (en) | 2017-03-21 | 2018-09-27 | Arbutus Biopharma Corporation | Substituted dihydroindene-4-carboxamides and analogs thereof, and methods using same |
JP2020528062A (ja) * | 2017-07-27 | 2020-09-17 | 江蘇恒瑞医薬股▲ふん▼有限公司 | ピペラジンヘテロアリール誘導体、その製造方法、およびその医薬での使用 |
TW201925199A (zh) * | 2017-11-02 | 2019-07-01 | 德商艾庫瑞斯公司 | 對b型肝炎病毒(hbv)具有活性的新穎高活性吡唑并哌啶取代的吲哚-2-甲醯胺 |
BR112020008762A2 (pt) * | 2017-11-02 | 2020-10-20 | Aicuris Gmbh & Co. Kg | indol-2-carboxamidas amino-tiazol substituídas altamente ativas inovadoras ativas contra o vírus da hepatite b (hbv) |
CN111801331A (zh) * | 2018-02-28 | 2020-10-20 | 诺华股份有限公司 | 吲哚-2-羰基化合物及其用于治疗乙型肝炎的用途 |
AR117188A1 (es) * | 2018-11-02 | 2021-07-21 | Aicuris Gmbh & Co Kg | Derivados de urea 6,7-dihidro-4h-pirazolo[1,5-a]pirazinas activas contra el virus de la hepatitis b (vhb) |
AR117189A1 (es) * | 2018-11-02 | 2021-07-21 | Aicuris Gmbh & Co Kg | Derivados de 6,7-dihidro-4h-pirazolo[1,5-a]pirazin indol-2-carboxamidas activos contra el virus de la hepatitis b (vhb) |
-
2019
- 2019-10-31 AR ARP190103180A patent/AR116947A1/es unknown
- 2019-10-31 UY UY0001038436A patent/UY38436A/es unknown
- 2019-11-01 WO PCT/EP2019/079965 patent/WO2020089453A1/en unknown
- 2019-11-01 AU AU2019370994A patent/AU2019370994A1/en not_active Abandoned
- 2019-11-01 CU CU2021000038A patent/CU20210038A7/es unknown
- 2019-11-01 SG SG11202104130SA patent/SG11202104130SA/en unknown
- 2019-11-01 EP EP19797715.0A patent/EP3873909A1/en not_active Withdrawn
- 2019-11-01 MX MX2021004986A patent/MX2021004986A/es unknown
- 2019-11-01 EA EA202191216A patent/EA202191216A1/ru unknown
- 2019-11-01 JP JP2021523657A patent/JP2022512871A/ja active Pending
- 2019-11-01 BR BR112021008361-8A patent/BR112021008361A2/pt not_active Application Discontinuation
- 2019-11-01 TW TW108139833A patent/TW202031661A/zh unknown
- 2019-11-01 KR KR1020217016302A patent/KR20210099562A/ko not_active Application Discontinuation
- 2019-11-01 US US17/290,357 patent/US20220363686A1/en active Pending
- 2019-11-01 CN CN201980072931.3A patent/CN113056467A/zh active Pending
- 2019-11-01 CA CA3118380A patent/CA3118380A1/en not_active Abandoned
-
2021
- 2021-04-20 IL IL282480A patent/IL282480A/en unknown
- 2021-04-29 EC ECSENADI202131085A patent/ECSP21031085A/es unknown
- 2021-04-29 CL CL2021001117A patent/CL2021001117A1/es unknown
- 2021-04-29 PH PH12021550979A patent/PH12021550979A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
PH12021550979A1 (en) | 2021-11-22 |
BR112021008361A2 (pt) | 2021-08-03 |
ECSP21031085A (es) | 2021-05-31 |
AU2019370994A1 (en) | 2021-05-27 |
US20220363686A1 (en) | 2022-11-17 |
CL2021001117A1 (es) | 2021-11-05 |
CN113056467A (zh) | 2021-06-29 |
EP3873909A1 (en) | 2021-09-08 |
CU20210038A7 (es) | 2021-12-08 |
WO2020089453A1 (en) | 2020-05-07 |
MX2021004986A (es) | 2021-06-15 |
AR116947A1 (es) | 2021-06-30 |
KR20210099562A (ko) | 2021-08-12 |
CA3118380A1 (en) | 2020-05-07 |
UY38436A (es) | 2020-05-29 |
IL282480A (en) | 2021-06-30 |
SG11202104130SA (en) | 2021-05-28 |
JP2022512871A (ja) | 2022-02-07 |
TW202031661A (zh) | 2020-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA202191223A1 (ru) | НОВЫЕ 6,7-ДИГИДРО-4Н-ПИРАЗОЛО[1,5-а]ПИРАЗИН-ИНДОЛ-2-КАРБОКСАМИДЫ, АКТИВНЫЕ ПРОТИВ ВИРУСА ГЕПАТИТА B (HBV) | |
EA202191219A1 (ru) | НОВЫЕ МОЧЕВИНО-6,7-ДИГИДРО-4H-ПИРАЗОЛО[1,5-a]ПИРАЗИНЫ, АКТИВНЫЕ ПРОТИВ ВИРУСА ГЕПАТИТА B (HBV) | |
EA202091114A1 (ru) | Новые высокоактивные пиразолопиперидин-замещенные индол-2-карбоксамиды, активные против вируса гепатита в (hbv) | |
EA202191216A1 (ru) | НОВЫЕ 6,7-ДИГИДРО-4Н-ПИРАЗОЛО[1,5-a]ПИРАЗИН-ИНДОЛ-2-КАРБОКСАМИДЫ, АКТИВНЫЕ ПРОТИВ ВИРУСА ГЕПАТИТА B (HBV) | |
EA202091113A1 (ru) | Новые высокоактивные аминотиазолзамещенные индол-2-карбоксамиды, активные в отношении вируса гепатита b (hbv) | |
PH12018550201A1 (en) | Hepatitis b antiviral agents | |
UY38483A (es) | Heterociclos funcionalizados como agentes antivirales | |
EA202090514A1 (ru) | Противовирусное средство против гепатита в | |
ATE539744T1 (de) | Hemmer von serin-protease, insbesondere von hepatitis-c-virus-ns3-ns4a-protease, mit einem kondensierten ringsystem | |
EA200970375A1 (ru) | Соединения и способы лечения вируса гепатита с | |
EA202192512A1 (ru) | Пиримидоновые производные с конденсированными кольцами для применения в лечении инфекции, вызванной hbv, или заболеваний, вызванных hbv | |
EA202191218A1 (ru) | НОВЫЕ МОЧЕВИНО-6,7-ДИГИДРО-4H-ПИРАЗОЛО[1,5-a]ПИРАЗИНЫ, АКТИВНЫЕ ПРОТИВ ВИРУСА ГЕПАТИТА В (HBV) | |
EA202092439A1 (ru) | Гетероароматические соединения, обладающие активностью против rsv | |
MX2021013085A (es) | Nuevas indol-2-carboxamidas activas contra el virus de la hepatitis b (vhb). | |
EA202191220A1 (ru) | НОВЫЕ МОЧЕВИНО-6,7-ДИГИДРО-4H-ПИРАЗОЛО[4,3-с]ПИРИДИНЫ, АКТИВНЫЕ ПРОТИВ ВИРУСА ГЕПАТИТА В (HBV) | |
MX2021013086A (es) | Nuevas fenil y piridil ureas activas contra el virus de la hepatitis b (vhb). | |
MX2022002231A (es) | Composiciones de anticuerpos y metodos para tratar la infeccion por el virus de la hepatitis b. | |
EA202091835A1 (ru) | Замещенные циклоалкилом пиразолопиримидины, обладающие активностью против rsv | |
EA202191221A1 (ru) | НОВЫЕ МОЧЕВИНО-6,7-ДИГИДРО-4H-ТИАЗОЛО[5,4-c]ПИРИДИНЫ, АКТИВНЫЕ ПРОТИВ ВИРУСА ГЕПАТИТА В (HBV) | |
EA202192967A1 (ru) | Новые индол-2-карбоксамиды, активные против вируса гепатита b (вгв) | |
EA202192969A1 (ru) | Новые оксалилпиперазины, активные против вируса гепатита b (вгв) | |
EA202192968A1 (ru) | Новые фенил- и пиридилмочевины, активные против вируса гепатита b (вгв) | |
EA202192965A1 (ru) | Новые индолизин-2-карбоксамиды, активные против вируса гепатита b (вгв) | |
EA202191404A1 (ru) | Функционализированные гетероциклы как противовирусные средства | |
MX2021013105A (es) | Nuevas oxalil piperazinas activas contra el virus de la hepatitis b (vhb). |